Skip to main content
PLOS One logoLink to PLOS One
. 2022 Apr 7;17(4):e0266689. doi: 10.1371/journal.pone.0266689

The contribution of avoidable factors in doubling or halving the odds of hypertension

Jalal Poorolajal 1,2, Younes Mohammadi 1,2, Amin Doosti-Irani 1,3, Saman Khosh-Manesh 1,*
Editor: Oliver Chen4
PMCID: PMC8989301  PMID: 35390081

Abstract

Background

Despite the well-known impact of fruit/vegetable consumption, physical activity, body mass index, waist-hip ratio, fasting blood glucose, and total cholesterol on blood pressure, the amount of exposure to these factors is required to halve or double the odds of hypertension is unknown, but it was investigated in this research.

Methods

The data used in this study are derived from results of the seventh Iranian national STEPS survey involving 30,542 adults aged 18 years or older. The questionnaire measured non-communicable disease risk factors covered three different levels including behavioral characteristics, physical and biochemical measurements. The level of exposure to factors necessary to reach the odds ratio of 0.5 or odds ratio of 2.0 was obtained from the coefficients of the multiple logistic regression model.

Results

An OR of 0.5 corresponds to 7 servings of fruit and vegetable consumption daily and burning of 7175 kcal through physical activity at work or recreation daily. An OR of 2.0 corresponds to an increase in body mass index of about 11 kg/m2, an increase in the waist-hip ratio of about 18%, an increase in fasting blood glucose of about 77 mg/dl, and an increase in total cholesterol of about 134 mg/dl.

Conclusion

The results of this study indicate how much fruit and vegetable and physical activity halve the odds of hypertension and how much increase in body mass index, the waist-hip ratio, fasting blood glucose, and total cholesterol can double the odds of hypertension. Such information may be useful for developing guidelines by policymakers.

Introduction

The pressure of blood against the walls of your arteries is known as blood pressure [1]. There are two types of high blood pressure (hypertension): primary (essential) hypertension (with no identifiable cause) and secondary hypertension (caused by an underlying condition). Essential or primary hypertension (high blood pressure) is the most prevalent form of hypertension, accounting for approximately 95% of all cases [2]. Hypertension affects an estimated 1.13 billion people worldwide or nearly 15% of the world’s population (1 in 4 men and 1 in 5 women) [3]. Hypertension is a severe but controllable or maybe preventable medical condition that dramatically increases the risk of heart disease, stroke, kidney disease, and vision loss [4].

Hypertension is caused by a complex interaction of genetic, metabolic, and behavioral factors such as fruit and vegetable consumption [5], overweight and obesity [6, 7], blood glucose [8], cholesterol [9], salt intake [10, 11], physical activity [12], alcohol consumption [13], vitamin D deficiency [14], and maybe several other unknown factors. Despite the impact of fruit/vegetable consumption, physical activity, body mass index (BMI), the waist-hip ratio, fasting blood sugar (FBS), and total cholesterol on blood pressure is widely investigated and well-known, however, the extent to which anyone of these factors can reach the odds ratio (OR) of 0.5 or 2.0 has not been thoroughly investigated. Knowing how much more exposure to a factor can halve or double the risk of an outcome of interest is critical in public health policy because it allows for better prioritization and planning of prevention programs. For example, an incremental rise of 20/10 mmHg in blood pressure can double the risk of cardiovascular disease, or participating in 150 minutes of moderate-intensity physical activity per week (or equivalent) will decrease the risk of ischemic heart disease by around 30% and the risk of diabetes by 27% [15].

At the moment, only a few studies have been conducted to determine how much exposure to these well-known factors requires to halve or double the risk of hypertension [16, 17]. According to these studies, an increase in age of about 9.4 years, an increase in BMI of about 10.3 kg/m2, an increase in the waist-to-hip ratio of about 0.5, and an increase in FBS of about 85.8 mg/dl can double the odds of hypertension [16]. In addition, excess weight loss may reduce the risk of hypertension by between 24% and 40% in people who are overweight and by between 40% and 54% in people who are obese [17]. In the current study, we used data of a national screening program (STEPS) to determine the amount of exposure to factors such as fruit/vegetable consumption, physical activity, BMI, the waist-hip ratio, fasting blood glucose, and total cholesterol requires to halve or double the odds of hypertension.

Methods

The data used in this study are derived from results of the seventh Iranian national survey conducted in 2016, which was a non-communicable disease (NCD) risk factor survey following the WHO STEPwise approach to surveillance (STEPS). This survey was a national project that was conducted for designing and implementing prevention programs against non-communicable diseases. There was no intervention in this study. Therefore, only verbal informed consent was obtained from participants. The study population included 30,542 adults aged 18 years or older. Pregnant women were excluded from the study.

STEPS is the WHO’s recommended tool for surveillance of NCDs and their risk factors. We used this tool to collect data and measure NCD risk factors covered three different levels, or ’Steps’, of risk factor assessment including (a) questionnaire, (b) physical measurements, and (c) biochemical measurements [18]. Demographic and behavioral information was gathered by a predefined questionnaire in a household setting. Physical measurements were also done in a household setting. Participants’ urine and blood samples were taken in the rural and urban Health Centers and then were sent to a central laboratory.

Basic demographic information included age and sex. Behavioral information included current tobacco use (average number of cigarettes per day), current alcohol consumption (average number of drinks per day/week/month), fruit and vegetable consumption (average servings per day), the median time spent in light/moderate/vigorous physical activity on average per day (minutes) at work, in the household, for transport, and during leisure time. Physical measurements included systolic and diastolic blood pressure (mmHg), height (cm), weight (kg), waist and hip circumference (cm). Biochemical measurements included fasting blood sugar (mg/dl), total cholesterol (mg/dl), HDL-cholesterol (mg/dl) and fasting triglycerides (mg/dl).

A serving size is standardized to represent 80 grams of fruit and vegetable consumption. For example, a banana or an apple of medium size piece; or ½ cup of chopped or cooked fruit; or 1 cup of raw green leafy vegetables such as spinach, salad, etc.; or ½ cup of tomatoes, carrots, pumpkin, corn, cabbage, fresh beans, onion, etc. was considered as one serving unit.

Some people were physically active in all domains (at work, in the household, for transport, and during leisure time), others were active in some domains or were not active in any of the settings. Physical activity was defined as follows [19]:

  1. Light-intensity activity is an activity that is classified as <3.5 kcal per minute (2.25 kcal on average), for example, housework, stretching, dancing slowly, leisurely sports (table tennis, playing catch), floating, boating, fishing, etc.

  2. Moderate-intensity activity is an activity that is classified as 3.5 to 7.0 kcal per minute (5.25 kcal on average); for example, activities that cause small increases in breathing or heart rate such as carrying light loads, brisk walking, hiking, gardening, fast dancing, swimming, cycling, etc.

  3. Vigorous-intensity activity is an activity that is classified as >7 kcal per minute (8.0 kcal on average); for example, activities that cause large increases in breathing or heart rate like such as carrying or lifting heavy loads, digging or construction work, loading furniture, playing football, running, fast swimming, fast cycling, aerobics, etc.

Blood pressure was measured at a sitting position three times allowing the arm to rest for three minutes between each of the readings. The mean of the last two measurements was considered as the participant’s blood pressure. Hypertension was defined as systolic and/or diastolic blood pressure ≥140/90 mmHg in adults aged 18 years and over [20]. The patients, who were on medication for hypertension prescribed by a doctor or other health workers, were considered hypertensive even if their blood pressure was normal at the time of measurement.

Waist circumference was measured at the level of the umbilicus. Hip circumference was measured while the measuring tape was horizontal all around the maximum circumference of the buttocks and snug without constricting. The measurements were taken without clothing, that is, directly over the skin in a private area, an area that has been screened off from other individuals within the household. The waist-hip ratio was used as an index of abdominal obesity.

The height was measured in a standing position without footwear (shoes, slippers, sandals, etc.) and headgear (hat, cap, hair bows, comb, ribbons, etc.). For measuring weight, the participants were asked to remove their footwear and take off any heavy belts and empty their pockets. BMI was defined as the weight in kilograms divided by the square of the height in meters and was expressed in units of kg/m2.

To measure fasting blood glucose (FBS) as well as high-density lipoprotein and total cholesterol, the participants were asked to fast for at least 12 hours before blood collection.

The simple and multiple logistic regression model was used to investigate the association between independent variables and hypertension. The OR was considered as the measure of association. The level of exposure to protective factors for hypertension that is necessary to reach the OR of 0.5 was obtained from the following formula: level = ln(0.5)/coefficient. Also, the level of exposure to risk factors for hypertension that is necessary to reach the OR of 2.0 was obtained from the following formula: level = ln(2.0)/coefficient. All analyses were performed at the 2-sided 0.05 significance level (which corresponds to a 95% confidence level) using the Stata software version 16 (StataCorp, College Station, TX, USA).

Results

Of the 30,542 participants 15,976 (52.3%) were female and 14,566 (47.7%) were male. The mean (SD) age of the participants was 44.50 (16.26) years with a range of 18 to 100 years. The median age was 42 years and the interquartile range (IQR) was 25 years. The prevalence of hypertension was 26.3% (7,842 out of 29,855). It was 27.4% (4,278 out of 15,640) in women and 25.1% (3,564 out of 14,215) in men.

The association between modifiable behavioral, anthropometric, and laboratory factors and hypertension is shown in Table 1. Based on the multiple logistic regression analysis, current daily cigarette smoking, alcohol consumption, dairy consumption, fish consumption, and high-density lipoprotein level had no significant association with hypertension. On the other hand, fruit and vegetable consumption and physical activity had an inversed association with hypertension. Whereas, BMI, waist-hip ratio, levels of blood glucose, and total cholesterol had a positive association with hypertension.

Table 1. The association between modifiable behavioral, anthropometric, and laboratory factors and hypertension.

Variables Unadjusted OR (95% CI) P-value Adjusted OR (95% CI) P-value
Number of current daily cigarette smoking (cigarette) 0.994 (0.989, 0.999) 0.040 0.996 (0.990, 1.003) 0.316
Alcohol consumption (times/week or month) 0.965 (0.937, 0.995) 0.023 0.982 (0.941, 1.025) 0.404
Fruit and vegetable consumption (serving/day) 0.951 (0.935, 0.969) 0.000 0.917 (0.894, 0.940) 0.000
Dairy consumption (glass/day) 0.968 (0.942, 0.994) 0.019 0.979 (0.943, 1.017) 0.283
Fish consumption (serving/week) 1.001 (0.970, 1.033) 0.936 0.968 (0.927, 1.011) 0.146
Physical activity at work or recreation (kcal/day) 0.998 (0.997, 0.999) 0.000 0.998 (0.997, 0.999) 0.000
Body mass index (kg/m2) 1.106 (1.100, 1.112) 0.000 1.064 (1.056, 1.071) 0.000
Waist-hip ratio (%) 1.054 (1.051, 1.057) 0.000 1.040 (1.036, 1.044) 0.000
Fasting blood glucose (mg/dl) 1.012 (1.011, 1.013) 0.000 1.009 (1.008, 1.010) 0.000
High density lipoprotein (mg/dl) 0.993 (0.990, 0.996) 0.000 1.003 (0.000, 1.006) 0.052
Total cholesterol (mg/dl) 1.007 (1.006, 1.008) 0.000 1.005 (1.004, 1.006) 0.000

Table 2 shows at what level of some continuous variables, the OR reach a level of 0.5 (indicating the reduction in the odds of developing hypertension) and 2.0 (an increase in the odds of developing hypertension). The interpretation of the coefficient of the multiple regression model is assuming other factors are held constant, for every 1-unit increase in the continuous variable, how much the log odds of hypertension increases. For example, 1 unit increase in fruit/vegetables consumption, the odds of hypertension is exp(-0.09263) = 0.91. Since this is on a continuous scale, a 7 unit increase in fruit/vegetable consumption corresponds to an odds ratio of exp(-0.09263×7) = 0.52. There is also variability associated with this estimate as is represented by the confidence interval of the model coefficient. Based on the above explanation, an OR of 0.5 corresponds to 7 servings of fruit and vegetable consumption daily or burning of 7175 kcal through physical activity at work or recreation daily. On the other hand, an OR of 2.0 corresponds to an increase in BMI of about 11 kg/m2, an increase in the waist-hip ratio of about 18%, an increase in FBS of about 77 mg/dl, or an increase in total cholesterol of about 134 mg/dl.

Table 2. Odds ratio estimates of hypertension based on a logarithmic scale using multiple logistic regression adjusted for all variables in the table.

Variables Coef. SE z P-value 95% CI Exposure level Effect
Fruit and vegetable consumption (serving/day) -0.09263 0.01174 -7.89 0.000 -0.11563 -0.06962 7
Physical activity at work or recreation (kcal/day) -0.00009 0.00002 -4.74 0.000 -0.00013 -0.00005 7175
Body mass index (kg/m2) 0.06155 0.00356 17.30 0.000 0.05458 0.06853 11
Waist-hip ratio (%) 0.03841 0.00196 19.64 0.000 0.03458 0.04225 18
Fasting blood glucose (mg/dl) 0.00895 0.00054 16.69 0.000 0.00790 0.01000 77
Total cholesterol (mg/dl) 0.00517 0.00047 10.97 0.000 0.00425 0.00610 134
Constant -7.57851 0.20134 -37.64 0.000 -7.97312 -7.18389 -

† The level of exposure to factors necessary to reach the odds ratio of 0.5 (downward green arrows) or odds ratio of 2.0 (upward red arrows).

Formula for protective factors: exposure level = ln(0.5)/Coef.

Formula for risk factors: exposure level = ln(2)/Coef.

Discussion

Our findings determined how much amount of exposure to factors such as fruit/vegetable consumption, physical activity, BMI, waist-hip ratio, fasting blood glucose, and total cholesterol can halve or double the odds of hypertension. The amount of exposure reported in this study may be used for the prioritization and planning of prevention programs. However, it is important to remember that risk and protective factors are not separate elements; they interact with each other rather. Therefore, they should be viewed as a whole. Diseases are promoted by risk factors, whereas inhibited by protective factors. The disease will not occur if risk and protective factors are in balance, or if protective factors overcome risk factors. Where risk factors overcome protective factors, however, the disease will occur [21].

The replicated OR of 0.5 or 2.0 reported here for each variable was adjusted for other model variables, in the table. In other words, we used a multiple logistic regression model accounting for all other variables. In multiple logistic regression, each estimated coefficient is the expected change in the log odds of hypertension for a unit increase in the corresponding variables, holding the other variables constant at a certain value.

Our findings indicated that burning of 7,175 kcal through physical activity at work or recreation daily can halve the odds of hypertension. Although this estimate is statistically and theoretically correct, burning such an amount of energy daily may not be practical for many people. Therefore, although physical activity helps lower blood pressure, physical activity alone is not enough to control hypertension. One must consider other factors that help lower blood pressure.

Based on our findings, consumption of every 7 servings/day of fruit and vegetable can halve the odds of hypertension. The evidence suggests that vegetables and fruits reduce blood pressure through various mechanisms. Basic research indicated the important pathways through which fruit and vegetable consumption may contribute to the regulation of blood pressure. A recent review indicated that flavonoids, which are abundant in dietary plants and herbs, play a role in reducing the onset or progression of many cardiovascular diseases, particularly hypertension [22]. Endothelium-dependent microvascular reactivity and plasma nitric oxide increase, while C-reactive protein and E-selectin decrease, in response to a diet rich with high-flavonoid fruits and vegetables [23]. Also, grape polyphenols can potentiate vasorelaxation and decrease blood pressure and endothelial dysfunction markers [24]. Also, quercetin, a type of flavonoid, was discovered to reduce systolic blood pressure by 3 mmHg [25].

According to our findings, for every 11 unit increase in BMI or 18% increase in the waist-hip ratio, the odds of hypertension doubles. A similar study reported that every 10.3 unit increase in BMI or 50% increase in the waist-hip ratio can double the odds of hypertension [16]. One reason we can give for this difference is that the study was conducted on 7611 people aged over 30 in a single province, while the present study was conducted on 30,542 people aged 18 or older in the whole country. The results of the current study are more valid and robust both in terms of sample size and population diversity.

A systematic review and meta-analysis reported that excess weight loss reduced the possibility of hypertension by between 24% and 40% in overweight people and by between 40% and 54% in obese people [17]. There have been many advances in understanding the pathophysiology of obesity-related hypertension. It is a multifactorial condition in which many possible pathogenic pathways are thought to be involved, including hyperinsulinemia and renin-angiotensin system activation, both of which result in renal tubular reabsorption, sodium accumulation, volume overload, and thus hypertension [2628]. On the other hand, weight loss can lead to a meaningfully reduced renin-angiotensin-aldosterone system in plasma and adipose tissue, as well as a reduction in insulin resistance, which may contribute to the reduced blood pressure [29, 30].

According to our results, if fasting blood glucose levels rise to 77 mg/dl, the chance of hypertension doubles. Diabetes and hypertension are two conditions that often coexist. A similar study showed that every 85.8 mg/dl increase in blood glucose can double the odds of hypertension [16]. In terms of etiology, the two disorders have a lot in common. Obesity, inflammation, oxidative stress, and insulin resistance are all common metabolic pathways in diabetes and hypertension [31]. Furthermore, metabolic disorders including dyslipidemia, hyperglycemia, and insulin resistance, caused by diabetes, result in a spectrum of physiological changes that induce vascular instability and put patients at risk for atherosclerosis [32]. Diabetes, in other words, increases the risk of hypertension, ischemic heart disease, and stroke in patients because it affects arteries and makes them targets for atherosclerosis [33, 34].

Based on our findings, for every 134 mg/dl increase in total cholesterol, the chance of hypertension doubles. Cholesterol may affect the regulation of blood pressure independently. Evidence showed that cholesterol induces endothelial dysfunction by reducing the bioavailability of endothelium-derived nitric oxide [35, 36]. Endothelium-dependent vasodilation is inversely related to total cholesterol levels [37].

We reported that current daily cigarette smoking had no significant effect on blood pressure. Literature indicated that the effect of smoking on blood pressure is complex with a variety of consequences. While tobacco smoking increases the aortic stiffness and blood pressure acutely, the chronic effects of tobacco smoking on blood pressure and the development of hypertension are uncertain or small [38, 39]. Population-based longitudinal studies are required to indicate whether the acute effect of tobacco smoking on blood pressure may contribute to the progression of chronic hypertension.

Our study was associated with a few limitations and potential biases as follows. First, salt consumption, which is an important factor in hypertension, although measured, was not included in our calculation due to inaccurate measurements. There was the same problem with measuring alcohol consumption. Second, in this survey, we only estimated the association between blood pressure and behavioral factors. The association does not, however, actually imply a cause-and-effect relationship. This might introduce bias in our results. Third, we used a large sample size and performed multiple logistic regression to estimate the pure impact of each factor on the odds of hypertension. However, it is almost impossible to have an ‘accurate’ estimate due to complex interactions between several factors affecting hypertension. Despite its limitations, we believe the results of the study are critical for public health policies and setting priorities for prevention programs.

Conclusion

This study indicated the amount of exposure to fruit/vegetable consumption, physical activity, body mass index, waist-hip ratio, fasting blood glucose, and total cholesterol requires to halve or double the odds of hypertension. Such information is critical in public health policy and may help develop guidelines and better prioritization and planning of prevention programs.

Supporting information

S1 Dataset

(DTA)

Acknowledgments

The data used in this study was the results of the seventh Iranian national STEPS survey. The authors thank the National Institute for Health Research (NIHR) of Iran for their support and access to the original data of this survey.

Ethics approval statement and consent to participate

The Ethics Committee of the Hamadan University of Medical Sciences approved this study (IR.UMSHA.REC.1399.554). The data was obtained from the National STEPS database.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The Vice-chancellor of Research and Technology of the Hamadan University of Medical Sciences supported this study (No. 9907295282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Centers for Disease Control and Prevention. High blood pressure: CDC; 2022 [updated 27 Sep 2021; cited 3 Feb 2022]. Available from: https://www.cdc.gov/bloodpressure/facts.htm.
  • 2.Hall JE. Guyton and Hall textbook of medical physiology. 13th ed. Philadelphia: Elsevier; 2016. [Google Scholar]
  • 3.World Health Organization. Hypertension Geneva: WHO; 2021 [updated 9 August 2019; cited 14 January 2021]. Available from: https://www.who.int/health-topics/hypertension/#tab=tab_1.
  • 4.World Health Organization. Improving hypertension control in 3 million people: country experiences of programme development and implementation. Geneva: WHO; 2020. [Google Scholar]
  • 5.Li B, Li F, Wang L, Zhang D. Fruit and Vegetables Consumption and Risk of Hypertension: A Meta-Analysis. Journal of clinical hypertension (Greenwich, Conn). 2016;18(5):468–76. Epub 2016/01/31. doi: 10.1111/jch.12777 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–209. doi: 10.1016/S0140-6736(05)67483-1 . [DOI] [PubMed] [Google Scholar]
  • 7.Poorolajal J, Zamani R, Mir-Moeini RS, Amiri B, Majzoobi MM, Erfani H, et al. Five-year evaluation of chronic diseases in Hamadan, Iran. Iran J Public Health. 2012;41(3):71–81. [PMC free article] [PubMed] [Google Scholar]
  • 8.Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601–10. doi: 10.1016/S0140-6736(12)60987-8 . [DOI] [PubMed] [Google Scholar]
  • 9.MacDonald CJ, Madika AL, Bonnet F, Fagherazzi G, Lajous M, Boutron-Ruault MC. Cholesterol and Egg Intakes, and Risk of Hypertension in a Large Prospective Cohort of French Women. Nutrients. 2020;12(5). Epub 2020/05/14. doi: 10.3390/nu12051350 ; PubMed Central PMCID: PMC7285051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ (Clinical research ed). 2013;346:f1325. doi: 10.1136/bmj.f1325 . [DOI] [PubMed] [Google Scholar]
  • 11.Poorolajal J, Zeraati F, Soltanian AR, Sheikh V, Maleki A. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials. PloS One. 2017;12(4):e0174967. doi: 10.1371/journal.pone.0174967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. Journal of hypertension. 2006;24(2):215–33. doi: 10.1097/01.hjh.0000199800.72563.26 . [DOI] [PubMed] [Google Scholar]
  • 13.Tasnim S, Tang C, Musini VM, Wright JM. Effect of alcohol on blood pressure. The Cochrane database of systematic reviews. 2020;7(7):Cd012787. Epub 2020/07/02. doi: 10.1002/14651858.CD012787.pub2 ; PubMed Central PMCID: PMC8130994 M Wright: none known. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sheikh V, Mozaiani-Monfared A, Gharakhani M, Poorolajal J. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial. Journal of Clinical Hypertension. 2020;22:1867–73. doi: 10.1111/jch.13926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.World Health Organization. Global Atlas on cardiovascular disease prevention and control. Geneva: WHO; 2011. [Google Scholar]
  • 16.Poorolajal J, Farbakhsh F, Mahjub H, Bidarafsh A, Babaee E. How much excess body weight, blood sugar, or age can double the risk of hypertension? Public health. 2016;133:14–8. Epub 2015/12/31. doi: 10.1016/j.puhe.2015.10.014 . [DOI] [PubMed] [Google Scholar]
  • 17.Poorolajal J, Hooshmand E, Bahrami M, Ameri P. How much excess weight loss can reduce the risk of hypertension? Journal of Public Health. 2017;39(3):e95–e102. doi: 10.1093/pubmed/fdw077 [DOI] [PubMed] [Google Scholar]
  • 18.World Health Organization. The WHO STEPwise approach to noncommunicable disease risk factor surveillance. Geneva: WHO; 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Center for Disease Control and Prevention. General physical activities defined by level of intensity Atlanta: CDC; 2021. [cited 7 March 2021]. Available from: https://www.cdc.gov/nccdphp/dnpa/physical/pdf/pa_intensity_table_2_1.pdf. [Google Scholar]
  • 20.Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex: 1979). 2018;71(6):e13–e115. Epub 2017/11/15. doi: 10.1161/hyp.0000000000000065 . [DOI] [PubMed] [Google Scholar]
  • 21.Poorolajal J. Equivalence model: A new description of causal inference. Epidemiol Health. 2020. doi: 10.4178/epih.e2020024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Maaliki D, Shaito AA, Pintus G, El-Yazbi A, Eid AH. Flavonoids in hypertension: a brief review of the underlying mechanisms. Current opinion in pharmacology. 2019;45:57–65. Epub 2019/05/19. doi: 10.1016/j.coph.2019.04.014 . [DOI] [PubMed] [Google Scholar]
  • 23.Macready AL, George TW, Chong MF, Alimbetov DS, Jin Y, Vidal A, et al. Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease—FLAVURS: a randomized controlled trial. The American journal of clinical nutrition. 2014;99(3):479–89. Epub 2014/01/24. doi: 10.3945/ajcn.113.074237 . [DOI] [PubMed] [Google Scholar]
  • 24.Barona J, Aristizabal JC, Blesso CN, Volek JS, Fernandez ML. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. The Journal of nutrition. 2012;142(9):1626–32. Epub 2012/07/20. doi: 10.3945/jn.112.162743 . [DOI] [PubMed] [Google Scholar]
  • 25.Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. The British journal of nutrition. 2009;102(7):1065–74. Epub 2009/05/01. doi: 10.1017/S0007114509359127 . [DOI] [PubMed] [Google Scholar]
  • 26.Re RN. Obesity-Related Hypertension. Ochsner J. 2009;9(3):133–6. [PMC free article] [PubMed] [Google Scholar]
  • 27.Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hypertension research: official journal of the Japanese Society of Hypertension. 2010;33(5):386–93. doi: 10.1038/hr.2010.9 . [DOI] [PubMed] [Google Scholar]
  • 28.Vaneckova I, Maletinska L, Behuliak M, Nagelova V, Zicha J, Kunes J. Obesity-related hypertension: possible pathophysiological mechanisms. The Journal of endocrinology. 2014;223(3):R63–78. doi: 10.1530/JOE-14-0368 . [DOI] [PubMed] [Google Scholar]
  • 29.Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension (Dallas, Tex: 1979). 2005;45(3):356–62. Epub 2005/01/05. doi: 10.1161/01.HYP.0000154361.47683.d3 . [DOI] [PubMed] [Google Scholar]
  • 30.Fryk E, Olausson J, Mossberg K, Strindberg L, Schmelz M, Brogren H, et al. Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study. EBioMedicine. 2021;65:103264. Epub 2021/03/14. doi: 10.1016/j.ebiom.2021.103264 ; PubMed Central PMCID: PMC7992078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bernard MY, Chao L. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012;14(2):160–6. doi: 10.1007/s11883-012-0227-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International journal of molecular sciences. 2020;21(5). Epub 2020/03/12. doi: 10.3390/ijms21051835 ; PubMed Central PMCID: PMC7084712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238(2):370–9. doi: 10.1016/j.atherosclerosis.2014.12.023 [DOI] [PubMed] [Google Scholar]
  • 34.Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. The Canadian journal of cardiology. 2018;34(5):575–84. doi: 10.1016/j.cjca.2017.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Chen JY, Ye ZX, Wang XF, Chang J, Yang MW, Zhong HH, et al. Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;97:423–8. doi: 10.1016/j.biopha.2017.10.122 [DOI] [PubMed] [Google Scholar]
  • 36.Hua J, Malinski T. Variable Effects Of LDL Subclasses Of Cholesterol On Endothelial Nitric Oxide/Peroxynitrite Balance—The Risks And Clinical Implications For Cardiovascular Disease. International journal of nanomedicine. 2019;14:8973–87. Epub 2019/12/11. doi: 10.2147/IJN.S223524 ; PubMed Central PMCID: PMC6874513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart (British Cardiac Society). 2013;99(24):1837–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Appel LJ. Smoking and hypertension: UpToDate; 2022. [updated 20 Aug 2019; cited 3 Feb 2022]. Available from: https://www.uptodate.com/contents/smoking-and-hypertension. [Google Scholar]
  • 39.Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. American journal of hypertension. 2007;20(6):637–41. Epub 2007/05/29. doi: 10.1016/j.amjhyper.2006.12.017 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Oliver Chen

2 Feb 2022

PONE-D-21-34725The Contribution of Avoidable Factors in Doubling or Halving the Risk of HypertensionPLOS ONE

Dear Dr. Poorolajal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Oliver Chen

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Funding Section of your manuscript:

“The Vice-chancellor of Research and Technology of the Hamadan University of Medical Sciences supported this study (No. 9907295282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please note that funding information should not appear in other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The Vice-chancellor of Research and Technology of the Hamadan University of Medical Sciences supported this study (No. 9907295282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Introduction.

1. For clarity, the authors need to address what different forms of hypertension are.

2. Knowing how much more exposure to a factor can halve or double the risk of an outcome of interest is critical in public health policy because it allows for better prioritization and planning of prevention programs. While it is good to know the impact of each factor on the risk of hypertension, it can be hard to have an accurate estimate due to their complex interactions. For example, fruit and vegetable consumption can affect blood pressure by influencing blood glucose, BMI, etc.

3. “At the moment, only a few studies have been conducted to determine how much exposure to these well-known factors requires to halve or double the risk of hypertension”. Please list out what factors had been examined in 2 previous studies and briefly summarize the findings.

Methods

4. “A serving size is standardized to represent 80 grams of fruit and vegetable consumption.” How were subjects instructed on the serving size? Would they need to weigh the amounts? Did they have a scale at home?

5. “light-intensity activity is an activity that is classified as <3.5 kcal….” Would subjects know how to assess physical activities they performed as light, moderate, or vigorous? The authors need to provide more information.

Results

6. “The mean (SD) age of the participants was 44.50 (6.26) years with a range of 18 to 100 years” Science age is a risk factor for hypertension; more detailed information can be provided, such as median and IQR.

7. The prevalence of hypertension was 26.3% (7,842 out of 30,542). What is the prevalence in men and women?

8. “Based on the multiple logistic regression analysis, current daily cigarette smoking, alcohol consumption, dairy consumption, fish consumption, and high-density lipoprotein level had no significant association with hypertension.” More data on the factors shall be presented since they were reported to associate with blood pressure.

9. “burning of 7175 kcal through physical activity at work or recreation daily.” Will this level of physical activity be practical? If not, the authors may need to use a different OR that can generate an estimate applicable for policy generation.

10. “an increase in FBS of about 77 mg/dl, and an increase in total cholesterol of about 134 mg/dl.” The magnitude of FBS and TC seems not so clinically relevant. What is the OR when FBS is increased by 39 and TC by 67?

Discussion

11. “The evidence suggests that vegetables and fruits reduce blood pressure through various mechanisms.” The authors shall need to list out the mechanisms with citations.

12. “A similar study reported that every 10.3 unit increase in BMI or 50% increase in the waist-hip ratio can double the risk of hypertension “ Since the same group published the study of the reference 15, the authors need to elaborate the differences between 2 study cohorts or the data of the same cohort were used in the analysis.

13. “both of which result in renal tubular reabsorption, sodium accumulation, volume overload, and thus hypertension25-27” After this sentence, it would be great to add the information on how weight loss can decrease the risk of hypertension.

14. The authors need to enrich the discussion section by including more information on the factors identified in the present study and blood pressure in the literature.

Reviewer #2: This paper explored the relationship between fruit/vegetable consumption, physical activity, body mass index, waist-hip-ratio, fasting blood glucose and total cholesterol in Iran and halving or doubling the risk of hypertension. And obtained how much fruit/vegetable and physical activity halve the risk of hypertension and how much increase in body mass index, the waist-hip-ratio, fasting blood glucose, and total cholesterol can double the risk of hypertension. These results may be useful for developing guidelines.

Reviewer #3: This goal of this manuscript was to explore the cut-offs associated with a given odds of having hypertension. Data appeared to have been obtained from a large survey study. The value of such information is noted in such a large scale study population. A few comments to consider.

1) The analysis performed used logistic regression which models the "odds" of an event rather than the "risk" of an event. There is a difference between "odds" and "risk". Revise to match the analysis.

2) The phrase "replicate the odds ratio" is not clear. Consider revising. Possibly something like the target odds ratio?

3) The methods state that "All statistical analysis were performed at a 95% significance level...". This should likely state that all analyses were performed at the 2-sided 0.05 significance level (which corresponds to a 95% confidence level).

4) It may be beneficial to consider rephrasing the analysis that was performed so that is clearer. The goal appear to be, at what level of some continuous variable, does the odds reach a level of 0.5 (indicating the reduction on the odds of having hypertension) and 2.0 (an increase in the odds of having hypertension). The interpretation of the coefficient of the multiple regression model is assuming other factors are held constant, for every 1-unit increase in the continuous variable, the log odds of hypertension increases by xx. For fruit and veggies, a 1 unit increase in fruit/veggie consumption, the odds of hypertension is exp(-0.09263)= 0.91. Since this is on a continuous scale, a 7 unit increase in fruit/veggie consumption corresponds to an odds ratio of exp(-0.09263*7)=0.52. There is also variability associated with this estimate as is represented by the confidence interval of the model coefficient.

5) The discussion section states: "The replicated OR of 0.5 or 2.0 reported here for each variable was adjusted for other model variables, in the table. In other words, we used a multiple logistic regression model accounting for all other variables. Therefore, we were able to measure the pure influence of each variable on blood pressure regardless of the other variables in the model."

However, in multiple logistic regression, each estimated coefficient is the expected change in the log odds of hypertension for a unit increase in the corresponding variables, holding the other variables constant at a certain value. Please revise this sentence with respect to the use of multiple logistic regression.

6) Participants that were already on hypertension medication were coded to be in the "hypertension" group regardless of whether or not medication controlled their hypertension. How many subjects reported being on hypertension medication? This could potentially change the meaning of the modelled odds in that it is the odds of being hypertensive or being medicated for hypertension.

7) To look at factors associated with increased odds of hypertension, what would happen if you did a subgroup analysis of those participants not currently medicated for hypertension? Are results consistent?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Oliver Chen

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-21-34725.docx

PLoS One. 2022 Apr 7;17(4):e0266689. doi: 10.1371/journal.pone.0266689.r002

Author response to Decision Letter 0


16 Feb 2022

Reviewer #1:

Introduction

1. For clarity, the authors need to address what different forms of hypertension are.

Answer: We addressed this issue by adding new information to the first paragraph of the introduction section.

2. Knowing how much more exposure to a factor can halve or double the risk of an outcome of interest is critical in public health policy because it allows for better prioritization and planning of prevention programs. While it is good to know the impact of each factor on the risk of hypertension, it can be hard to have an accurate estimate due to their complex interactions. For example, fruit and vegetable consumption can affect blood pressure by influencing blood glucose, BMI, etc.

Answer: That is right. We can just “estimate” the impact of factors on hypertension but it is not possible to “accurately measure” the impact of a single factor on hypertension. Therefore, we added another sentence to the limitations of the study and explained this issue.

3. “At the moment, only a few studies have been conducted to determine how much exposure to these well-known factors requires to halve or double the risk of hypertension”. Please list out what factors had been examined in 2 previous studies and briefly summarize the findings.

Answer: We added a phrase to the introduction section and briefly summarize the findings.

Methods

4. “A serving size is standardized to represent 80 grams of fruit and vegetable consumption.” How were subjects instructed on the serving size? Would they need to weigh the amounts? Did they have a scale at home?

Answer: This survey was conducted based on the WHO STEPwise guideline. This guideline gave several examples to the participants in order to let them know how much a serving size of fruits and vegetables was. We gave some of these examples in the 4th paragraph of the methods section to clarify this ambiguity.

5. “light-intensity activity is an activity that is classified as <3.5 kcal….” Would subjects know how to assess physical activities they performed as light, moderate, or vigorous? The authors need to provide more information.

Answer: As we explained for the previous question, this survey was performed according to the WHO STEPwise guideline. This guideline gave several examples to the participants in order to let them differentiate between low, moderate, and vigorous intensity physical activity. We gave some of these examples in the 5th paragraph of the methods section to clarify this ambiguity.

Results

6. “The mean (SD) age of the participants was 44.50 (6.26) years with a range of 18 to 100 years” Science age is a risk factor for hypertension; more detailed information can be provided, such as median and IQR.

Answer: We added the median and IQR of age to the first paragraph of the results section.

7. The prevalence of hypertension was 26.3% (7,842 out of 30,542). What is the prevalence in men and women?

Answer: We reported the prevalence of hypertension in men and women separately in the first paragraph of the results section.

8. “Based on the multiple logistic regression analysis, current daily cigarette smoking, alcohol consumption, dairy consumption, fish consumption, and high-density lipoprotein level had no significant association with hypertension.” More data on the factors shall be presented since they were reported to associate with blood pressure.

Answer: We discussed about this issue in details in the discussion section.

9. “burning of 7175 kcal through physical activity at work or recreation daily.” Will this level of physical activity be practical? If not, the authors may need to use a different OR that can generate an estimate applicable for policy generation.

Answer: We gave an explanation in the third paragraph of the discussion section to clarify this issue.

10. “an increase in FBS of about 77 mg/dl, and an increase in total cholesterol of about 134 mg/dl.” The magnitude of FBS and TC seems not so clinically relevant. What is the OR when FBS is increased by 39 and TC by 67?

Answer: We added two formulas to the footnote of the Table 2 to answer this question in another way. The exposure levels of protective and risk factors that we estimated in the last column of the Table 2 are based on OR of 0.5 and 2.0, respectively. However, if someone wants to estimate the exposure levels of protective and risk factors that change the OR (for example) to 0.7 or 1.5, he/she just need to put these figures in the formula and calculate the formula to reach the answer.

Discussion

11. “The evidence suggests that vegetables and fruits reduce blood pressure through various mechanisms.” The authors shall need to list out the mechanisms with citations.

Answer: The references #22, #23, #24, and #25 (which are mentioned in the same paragraph) explain these mechanisms. We moved the above sentence to the beginning of the paragraph to remove this ambiguity.

12. “A similar study reported that every 10.3 unit increase in BMI or 50% increase in the waist-hip ratio can double the risk of hypertension “ Since the same group published the study of the reference 15, the authors need to elaborate the differences between 2 study cohorts or the data of the same cohort were used in the analysis.

Answer: We added additional information to the paragraph in the discussion section and explained the reason for the difference between the two studies.

13. “both of which result in renal tubular reabsorption, sodium accumulation, volume overload, and thus hypertension25-27” After this sentence, it would be great to add the information on how weight loss can decrease the risk of hypertension.

Answer: We added an explanation to the end of this sentence and cited it.

14. The authors need to enrich the discussion section by including more information on the factors identified in the present study and blood pressure in the literature.

Answer: We added some new paragraphs and several phrases to the discussion section and added six new references to the manuscript. The number of references increased from 34 to 40.

Reviewer #2:

This paper explored the relationship between fruit/vegetable consumption, physical activity, body mass index, waist-hip-ratio, fasting blood glucose and total cholesterol in Iran and halving or doubling the risk of hypertension. And obtained how much fruit/vegetable and physical activity halve the risk of hypertension and how much increase in body mass index, the waist-hip-ratio, fasting blood glucose, and total cholesterol can double the risk of hypertension. These results may be useful for developing guidelines.

Answer: Thank you.

Reviewer #3:

This goal of this manuscript was to explore the cut-offs associated with a given odds of having hypertension. Data appeared to have been obtained from a large survey study. The value of such information is noted in such a large scale study population. A few comments to consider.

1) The analysis performed used logistic regression which models the "odds" of an event rather than the "risk" of an event. There is a difference between "odds" and "risk". Revise to match the analysis.

Answer: We changed the words “risk” related to the results of this study to words “odds”.

2) The phrase "replicate the odds ratio" is not clear. Consider revising. Possibly something like the target odds ratio?

Answer: We paraphrased the whole main text and replaced the word “replicate” with the word “reach”.

3) The methods state that "All statistical analysis were performed at a 95% significance level...". This should likely state that all analyses were performed at the 2-sided 0.05 significance level (which corresponds to a 95% confidence level).

Answer: We replaced the original sentence with the suggested sentence.

4) It may be beneficial to consider rephrasing the analysis that was performed so that is clearer. The goal appear to be, at what level of some continuous variable, does the odds reach a level of 0.5 (indicating the reduction on the odds of having hypertension) and 2.0 (an increase in the odds of having hypertension). The interpretation of the coefficient of the multiple regression model is assuming other factors are held constant, for every 1-unit increase in the continuous variable, the log odds of hypertension increases by xx. For fruit and veggies, a 1 unit increase in fruit/veggie consumption, the odds of hypertension is exp(-0.09263)= 0.91. Since this is on a continuous scale, a 7 unit increase in fruit/veggie consumption corresponds to an odds ratio of exp(-0.09263*7)=0.52. There is also variability associated with this estimate as is represented by the confidence interval of the model coefficient.

Answer: We added the above useful and excellent explanation to end of results section.

5) The discussion section states: "The replicated OR of 0.5 or 2.0 reported here for each variable was adjusted for other model variables, in the table. In other words, we used a multiple logistic regression model accounting for all other variables. Therefore, we were able to measure the pure influence of each variable on blood pressure regardless of the other variables in the model."

However, in multiple logistic regression, each estimated coefficient is the expected change in the log odds of hypertension for a unit increase in the corresponding variables, holding the other variables constant at a certain value. Please revise this sentence with respect to the use of multiple logistic regression.

Answer: We replaced the original sentence with the suggested sentence.

6) Participants that were already on hypertension medication were coded to be in the "hypertension" group regardless of whether or not medication controlled their hypertension. How many subjects reported being on hypertension medication? This could potentially change the meaning of the modelled odds in that it is the odds of being hypertensive or being medicated for hypertension.

Answer: 22,013 out of 7,842 hypertensive patients used anti-hypertensive medications at the time of study. However, using or not using anti-hypertensive medication had no effect on the results of this study. Because, we considered hypertension as a dichotomous (0, 1) outcome in this study. If considered blood pressure as a continuous variable, using anti-hypertensive medication may affect outcome and hence the results. But it was not the case in this study.

7) To look at factors associated with increased odds of hypertension, what would happen if you did a subgroup analysis of those participants not currently medicated for hypertension? Are results consistent?

Answer: In this study we considered to different approaches to distinguish hypertensive patients from non-hypertensive ones. Measuring the blood pressure (as explained in the methods section) was the first approach. We also assessed participants’ history of using anti-hypertensive medication as an alternative approach to diagnose the hypertensive patients. We considered hypertension as the binomial outcome of interest in this study giving code #1 to the patients and code #0 to non-patients. Taking a history of using anti-hypertensive medication is just a diagnostic approach for increasing the sensitivity of diagnosis of the outcome. Therefore, using or not using anti-hypertensive medication had no effect on the results of this study.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Oliver Chen

16 Mar 2022

PONE-D-21-34725R1The Contribution of Avoidable Factors in Doubling or Halving the Odds of HypertensionPLOS ONE

Dear Dr. Poorolajal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 30 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Oliver Chen

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Specific comments:

1. "Hypertension affects an estimated 1.13 billion people worldwide or nearly 15% of the world's population (1 in 4 men and 1 in 5 women)" in the article does not indicate the reference source.

2. Whether "fasting blood glucose, high-density lipoprotein and total cholesterol" were tested in the field or at a testing facility.

3. Whether people with hypertension were included in the group whose blood pressure was controlled through lifestyle change.

4. Which questionnaire was used for information collection, and whether the reliability and validity of the questionnaire have been verified.

5. It is suggested to update the references.

Reviewer #3: All comments have been addressed and the appropriate adjustments have been made to the manuscript. No further comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Apr 7;17(4):e0266689. doi: 10.1371/journal.pone.0266689.r004

Author response to Decision Letter 1


22 Mar 2022

Editor’s comments

Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Answer: We added the following phrase to the first paragraph in the Methods section. “This survey was a national project that was conducted for designing and implementing prevention programs against non-communicable diseases. There was no intervention in this study. Therefore, only verbal informed consent was obtained from participants. The study population included 30,542 adults aged 18 years or older. Pregnant women were excluded from the study.”

Reviewer #2: Specific comments:

1. "Hypertension affects an estimated 1.13 billion people worldwide or nearly 15% of the world's population (1 in 4 men and 1 in 5 women)" in the article does not indicate the reference source.

Answer: The reference was added.

2. Whether "fasting blood glucose, high-density lipoprotein, and total cholesterol" were tested in the field or at a testing facility.

Answer: Participants’ urine and blood samples were taken in the rural and urban Health Centers and then were sent to a central laboratory. We revised the main text and clarified this issue.

3. Whether people with hypertension were included in the group whose blood pressure was controlled through lifestyle change.

Answer: We applied different approaches to distinguish hypertensive patients from non-hypertensive ones. Measuring the blood pressure (as explained in the Methods section) was the first approach. We also assessed participants’ history of using the antihypertensive medication as an alternative approach to diagnose hypertensive patients. We considered hypertension as the binomial outcome of interest in this study giving code #1 to the patients and code #0 to non-patients. Taking a history of using anti-hypertensive medication is just a diagnostic approach for increasing the sensitivity of diagnosis of the outcome. Therefore, using or not using antihypertensive medication did not affect the results of this study.

4. Which questionnaire was used for information collection, and whether the reliability and validity of the questionnaire have been verified.

Answer: STEPS is the WHO's recommended tool for surveillance of NCDs and their risk factors. We used this tool to collect data and measure NCD risk factors. We added an explanation to the methods section to clarify this issue.

5. It is suggested to update the references.

Answer:

Vallance 1989 was replaced with Maruhashi 2013.

Clarkson 1996 was replaced with Petrie 2018.

Creager 1997 was replaced with Chen 2018.

Hayakawa 1999 was replaced with Hua 2019.

Beckman 2002 was replaced with Poznyak 2020.

Whelton 2002 was replaced with Tasnim 2020.

Chobanian 2003 was replaced with Whelton 2018.

Rice-Evans 2003 was replaced with Maaliki 2019.

Accordingly, all references are from 2005 and beyond, and about half of them are from the last 5 years.

Reviewer #3

All comments have been addressed and the appropriate adjustments have been made to the manuscript. No further comments.

Answer: Thank you.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Oliver Chen

25 Mar 2022

The Contribution of Avoidable Factors in Doubling or Halving the Odds of Hypertension

PONE-D-21-34725R2

Dear Dr. Poorolajal,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Oliver Chen

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Oliver Chen

29 Mar 2022

PONE-D-21-34725R2

The Contribution of Avoidable Factors in Doubling or Halving the Odds of Hypertension

Dear Dr. Poorolajal:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Oliver Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (DTA)

    Attachment

    Submitted filename: PONE-D-21-34725.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES